Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Keith Kaye

General ID · RU

View

Dr. Rochelle Walensky

General ID · Harvard Medical School

View

Dr. Erin Bonura

General ID · OHSU

View

Dr. Nizar Wehbi

General ID

View

Dr. Robert Schooley

General ID · UCSD

View

Dr. Priya Nori

General ID · MMC

View

Dr. Jan Patterson

General ID · UTHSCSA

View

Dr. Kavita Bhavan

General ID · Dallas County Hospital District

View

Dr. John Goldman

General ID · UPMC Central PA

View

Dr. Gonzalo Bearman

General ID · Medical College of Virginia

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Fosmanogepix Treatment for Coccidioidomycosis Under an Expanded Access Program.

    Oct 7, 2026DOI: 10.1093/cid/ciag271Journal ArticleCID

    Written by: Stuart H CohenPaul AllynFelicia C ChowJennifer RatheDeepa D NanayakkaraGerald HutflesTara VijayanEthan A SmithChristopher F SalingDan IlgesHaran T SchlammGeorge R Thompson

    Find these authors on Roon

    TV
    Dr. Tara Vijayan
    General ID · UCLA

    Summary

    Coccidioidomycosis is an invasive fungal infection that can disseminate and cause severe disease. Fosmanogepix ("gepix"), a first-in-class antifungal available via expanded access (NCT06433128), was successful in 8/11 patients (meningitis, 6/8 [75%]; non-meningeal dissemination, 2/3 [66%]) and was well tolerated for a median treatment duration of 208 days.
    TVDr. Tara Vijayan

    Dr. Tara Vijayan

    Infectious Disease · General Infectious Disease
    University of California, Los Angeles
    tarav